Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions

References

• Andersson M, Kjellgren A. 2017. The slippery slope of flubromazolam: experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum. Nordic Stud Alcohol Drugs. 34(3):217–229.
   Web of Science ®Google Scholar
• Arnaud KO, Sharpe D. 2022. Contextual parameters associated with positive and negative mental health in recreational psychedelic users. J Psychoact Drugs. 1:1–10.
   Google Scholar
• Australian Institute of Health and Wellbeing 2020. National drug strategy household survey 2019. Canberra: Commonwealth of Australia.
   Google Scholar
• Baggott MJ, Erowid E, Erowid F, Galloway GP, Mendelson J. 2010. Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug Alcohol Depend. 111(3):250–256.
   PubMed Web of Science ®Google Scholar
• Barratt MJ. 2012. The efficacy of interviewing young drug users through online chat. Drug Alcohol Rev. 31(4):566–572.
   PubMed Web of Science ®Google Scholar
• Beharry S, Gibbons S. 2016. An overview of emerging and new psychoactive substances in the United Kingdom. Forensic Sci Int. 267:25–34.
   PubMed Web of Science ®Google Scholar
• Blewett DB, Chwelos N. 1959. Handbook for the therapeutic use of lysergic acid diethylamide-25: individual and group procedures. [accessed 2022 Jan 11]. https://maps.org/research-archive/ritesofpassage/lsdhandbook.pdf.
   Google Scholar
• Bogenschutz MP. 2013. Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. Curr Drug Abuse Rev. 6(1):17–29.
   PubMedGoogle Scholar
• Bogenschutz MP, Forcehimes AA. 2017. Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism. J Human Psychol. 57(4):389–414.
   Web of Science ®Google Scholar
• Braun V, Clarke V. 2006. Using thematic analysis in psychology. Qual Res Psychol. 3(2):77–101.
   Google Scholar
• Braun V, Clarke V. 2021. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qual Res Psychol. 18(3):328–325.
   Web of Science ®Google Scholar
• Brennan BP, Kanayama G, Pope HG. 2013. Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict. 22(2):158–161.
   PubMed Web of Science ®Google Scholar
• Bright SJ, Bishop B, Kane R, Marsh A, Barratt MJ. 2013. Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. Int J Drug Policy. 24(3):231–237.
   PubMed Web of Science ®Google Scholar
• Boothroyd D, Lewis S. 2016. Online drug scenes and harm reduction from below as phronesis. Contemp Drug Prob. 43(3):293–307.
   Google Scholar
• Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. 2016. Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. J Psychopharmacol. 30(12):1268–1278.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ. 2015. LSD enhances suggestibility in healthy volunteers. Psychopharmacology (Berl). 232(4):785–794.
   PubMed Web of Science ®Google Scholar
• Charmaz K. 2004. Premises, principles, and practices in qualitative research: revisiting the foundations. Qual Health Res. 14(7):976–993.
   PubMed Web of Science ®Google Scholar
• Chiauzzi E, Dasmahapatra P, Lobo K, Barratt MJ. 2013. Participatory research with an online drug forum: a survey of user characteristics, information sharing, and harm reduction views. Subst Use Misuse. 48(8):661–670.
   PubMed Web of Science ®Google Scholar
• Clarke V, Braun V. 2014. Thematic analysis. In: Teo, T, editor. Encyclopaedia of critical psychology. New York (NY): Springer. https://doi.org/10.1007/978-1-4614-5583-7_311
   Google Scholar
• Davey Z, Schifano F, Corazza O, Deluca P, Psychonaut Web Mapping Group. 2012. e-Psychonauts: conducting research in online drug forum communities. J Ment Health. 21(4):386–394.
   PubMed Web of Science ®Google Scholar
• Di Vincenzo JD, Siegel A, Lipsitz O, Ho R, Teopiz KM, Ng J, Lui LMW, Lin K, Cao B, Rodrigues NB, et al. 2021. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: a systematic review. J Psychiatr Res. 137:232–241.
   PubMed Web of Science ®Google Scholar
• Engel L, Bright S, Barratt M, Allen M. 2021. Positive drug stories: possibilities for agency and positive subjectivity for harm reduction. Addict Res Theory. 29(5):363–371.
   Web of Science ®Google Scholar
• Enghoff O, Aldridge J. 2019. The value of unsolicited online data in drug policy research. Int J Drug Policy. 73:210–218.
   PubMed Web of Science ®Google Scholar
• Forsyth AJM. 2012. Virtually a drug scare: mephedrone and the impact of the Internet on drug news transmission. Int J Drug Policy. 23(3):198–209.
   PubMed Web of Science ®Google Scholar
• Fotiou E. 2020. The role of Indigenous knowledges in psychedelic science. J Psychedelic Stud. 4(1):16–23.
   Google Scholar
• Garcia-Romeu A, Richards WA. 2018. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. Int Rev Psychiatry. 30(4):291–316.
   PubMed Web of Science ®Google Scholar
• Global Drug Survey 2017. [accessed 2022 Jan 11]. https://www.globaldrugsurvey.com/wp-content/themes/globaldrugsurvey/results/GDS2017_key-findings-report_final.pdf.
   Google Scholar
• Grof S. 1980. LSD psychotherapy. Nashville: Hunter House.
   Google Scholar
• Grof S, Goodman LE, Richards WA, Kurland AA. 1973. LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsy. 8(3):129–144.
   PubMedGoogle Scholar
• Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, Nutt D, Daws RE, Hampshire ADG, Lorenz R, et al. 2018. Predicting responses to psychedelics: a prospective study. Front Pharmacol. 9:897.
   PubMed Web of Science ®Google Scholar
• Hausner M, Doležal V. 1963. Group and individual psychotherapy under LSD. Psychother Psychosom. 11(1):39–59.
   Google Scholar
• Hughes S, Cohen D. 2011. Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet. J Med Internet Res. 13(3):e53–15.
   PubMed Web of Science ®Google Scholar
• Johnson MW, Richards WA, Griffiths RR. 2008. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 22(6):603–620.
   PubMed Web of Science ®Google Scholar
• Kafka JS, Gaarder KR. 1964. Some effects of the therapist’s LSD experience on his therapeutic work. APT. 18(2):236–243.
   Web of Science ®Google Scholar
• Krebs T, Johansen PØ. 2013. Over 30 million psychedelic users in the United States. F1000Res. 2:98.
   PubMedGoogle Scholar
• Leary T, Metzner R, Alpert R. 1964. The psychedelic experience: a manual based on the Tibetan book of the dead. New York (NY): Citadel Press.
   Google Scholar
• Metzner R. 1998. Hallucinogenic drugs and plants in psychotherapy and shamanism. J Psychoactive Drugs. 30(4):333–341.
   PubMed Web of Science ®Google Scholar
• Michaels TI, Purdon J, Collins A, Williams MT. 2018. Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry. 18(1):1–14.
   PubMedGoogle Scholar
• Miller PG, Sønderlund AL. 2010. Using the internet to research hidden populations of illicit drug users: a review. Addiction. 105(9):1557–1567.
   PubMed Web of Science ®Google Scholar
• Mithoefer MC. 2017. A manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder. https://s3-us-west-1.amazonaws.com/mapscontent/research-archive/mdma/TreatmentManual_MDMAAssistedPsychotherapyVersion+8.1_22+Aug2017.pdf
   Google Scholar
• Montagne M. 2008. Drugs on the internet. I: introduction and web sites on psychedelic drugs. Subst Use Misuse. 43(1):17–25.
   PubMed Web of Science ®Google Scholar
• Móró L, Simon K, Bárd I, Rácz J. 2011. Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users. J Psychoactive Drugs. 43(3):188–198.
   PubMed Web of Science ®Google Scholar
• Nichols DE. 2016. Psychedelics. Pharmacol Rev. 68(2):264–355.
   PubMed Web of Science ®Google Scholar
• Nielson EM, Guss J. 2018. The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training. J Psychedelic Stud. 2(2):64–73.
   Google Scholar
• Orsolini L, Francesconi G, Papanti GD, Giorgetti A, Schifano F. 2015. Profiling online recreational/prescription drugs’ customers and overview of drug vending virtual marketplaces. J Clin Psychiatry. 55(9):391–393.
   Google Scholar
• Pahnke WN, Kurland AA, Unger S, Savage C, Grof S. 1971. The experimental use of psychedelic (LSD) psychotherapy. Int Z Klin Pharmakol Ther Toxikol. 4(4):446–454.
   PubMedGoogle Scholar
• Paul MJ, Chisolm MS, Johnson MW, Vandrey RG, Dredze M. 2016. Assessing the validity of online drug forums as a source for estimating demographic and temporal trends in drug use. J Addict Med. 10(5):324–330.
   PubMed Web of Science ®Google Scholar
• Phelps J. 2017. Developing guidelines and competencies for the training of psychedelic therapists. J Human Psychol. 57(5):450–487.
   Web of Science ®Google Scholar
• Richards WA. 2008. The phenomenology and potential religious import of states of consciousness facilitated by psilocybin. Arch Psychol Relig. 30(1):189–200.
   Google Scholar
• Rönkä S, Katainen A. 2017. Non-medical use of prescription drugs among illicit drug users: a case study on an online drug forum. Int J Drug Policy. 39:62–68.
   PubMed Web of Science ®Google Scholar
• Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A. 2021. Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review. J Psychiatr Res. 137:273–282.
   PubMed Web of Science ®Google Scholar
• Roseman L, Nutt DJ, Carhart-Harris RL. 2018. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol. 8:974.
   PubMed Web of Science ®Google Scholar
• Santos HC, Marques JG. 2021. What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review. Porto Biomedical J. 6(1):e128. DOI:10.1097/j.pbj.0000000000000128
   PubMedGoogle Scholar
• Schifano F, Deluca P, Baldacchino A, Peltoniemi T, Scherbaum N, Torrens M, Farre M, Flores I, Rossi M, Eastwood D, et al. 2006. Drugs on the web; the Psychonaut 2002 EU project. Prog Neuropsychopharmacol Biol Psychiatry. 30(4):640–646.
   PubMed Web of Science ®Google Scholar
• Smith KW, Sicignano DJ, Hernandez AV, White CM. 2021. MDMA‐assisted psychotherapy for treatment of posttraumatic stress disorder: a systematic review with meta‐ analysis. J Clin Pharmacol. 62(4):463-471.
   PubMed Web of Science ®Google Scholar
• Soussan C, Andersson M, Kjellgren A. 2018. The diverse reasons for using Novel Psychoactive Substances—A qualitative study of the users' own perspectives. Int J Drug Policy. 52:71–78.
   PubMed Web of Science ®Google Scholar
• Soussan C, Kjellgren A. 2014. Harm reduction and knowledge exchange-a qualitative analysis of drug-related Internet discussion forums. Harm Reduct J. 11(1):25.
   PubMed Web of Science ®Google Scholar
• Spencer AM. 1964. Modifications in the technique of LSD therapy. Compr Psychiatry. 5(4):232–252.
   PubMed Web of Science ®Google Scholar
• Sutherland R, Bruno R, Peacock A, Lenton S, Matthews A, Salom C, Dietze P, Butler K, Burns L, Barratt MJ. 2017. Motivations for new psychoactive substance use among regular psychostimulant users in Australia. Int J Drug Policy. 43:23–32.
   PubMed Web of Science ®Google Scholar
• Swift JK, Callahan JL, Cooper M, Parkin SR. 2018. The impact of accommodating client preference in psychotherapy: a meta-analysis. J Clin Psychol. 74(11):1924–1937.
   PubMed Web of Science ®Google Scholar
• Thal SB, Bright SJ, Sharbanee JM, Wenge T, Skeffington PM. 2021. Current perspective on the therapeutic preset for substance-assisted psychotherapy. Front Psychol. 12:617224.
   PubMed Web of Science ®Google Scholar
• Thal S, Engel LB, Bright SJ. 2022. Presence, trust, and empathy: preferred characteristics of psychedelic carers. J Human Psychol. 002216782210813.
   Web of Science ®Google Scholar
• Temple EC, Brown RF. 2011. A comparison of internet-based participant recruitment methods: Engaging the hidden population of cannabis users in research. J Res Pract. 7(2):D2–D2.
   Google Scholar
• World Drug Report. 2019. United Nations publication, Sales No. E.19.XI.8.
   Google Scholar
• Watts R. 2021. Psilcybin for depression: the ACE (Accept/Connect/Embody) model manual. Open Science Framework. DOI:10.31234/osf.io/5x2bu
   Google Scholar
• Williams MT, Labate BC. 2019. Diversity, equity, and access in psychedelic medicine. J Psych Studies. 4(1):1–3.
   Google Scholar
• Zawilska JB. 2015. "Legal Highs"-an emerging epidemic of novel psychoactive substances.” Int Rev Neurobiol. 120:273–300.
   PubMed Web of Science ®Google Scholar